Contributions of human tissue analysis to understanding the mechanisms of loosening and osteolysis in total hip replacement

Acta Biomaterialia

Volumn 10, Issue 6, 2014, Pages 2354-2366

  Gallo, Jiri ^a   Vaculova, Jana ^b   Goodman, Stuart B ^c   Konttinen, Yrjö T ^d,e,f   Thyssen, Jacob P ^g  

^a PALACKÝ UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL OSTRAVA   (Czech Republic)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HOSPITAL DISTRICT OF HELSINKI AND UUSIMAA   (Finland)

^e ORTON ORTHOPAEDIC HOSPITAL   (Finland)

^f COXA Hospital for Joint Replacement ^*  (Finland)

^g UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Aseptic loosening; Immunostaining; Osteolysis; Tissue analysis; Total hip

Indexed keywords

CELL CULTURE; CELL PROLIFERATION; HIP PROSTHESES; HISTOLOGY; NITRIC OXIDE; TISSUE;

ASEPTIC LOOSENING; BONE-IMPLANT INTERFACES; CELL POPULATIONS; CONTROL SAMPLES; HUMAN TISSUES; IMMUNOSTAINING; OSTEOLYSIS; TISSUE ANALYSIS; TOTAL HIP; TOTAL HIP ARTHROPLASTY;

ARTHROPLASTY;

CYTOKINE; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; OSTEOCLAST DIFFERENTIATION FACTOR; TOLL LIKE RECEPTOR;

ARTICLE; BONE IMPLANT; CELL POPULATION; CHRONIC INFLAMMATION; COLLAGEN DEGRADATION; COMPREHENSION; CYTOKINE RESPONSE; DELAYED HYPERSENSITIVITY; DENDRITIC CELL; FIBROSIS; FOREIGN BODY GRANULOMA; FOREIGN BODY REACTION; FROZEN SECTION; GIANT CELL; HISTOLOGY; HISTOPATHOLOGY; HUMAN; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; INNATE IMMUNITY; MACROPHAGE; MAST CELL; META ANALYSIS; NEUTROPHIL; OSTEOLYSIS; PERIPROSTHETIC FRACTURE; PRIORITY JOURNAL; PROSTHESIS LOOSENING; PROTEIN EXPRESSION; REOPERATION; SYSTEMATIC REVIEW; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; CONNECTIVE TISSUE; HIP ARTHROPLASTY; PATHOPHYSIOLOGY;

ARTHROPLASTY, REPLACEMENT, HIP; CONNECTIVE TISSUE; HUMANS; OSTEOLYSIS;

EID: 84899659860     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2014.02.003     Document Type: Review

References (143)

1. Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am Vol 2007;89:780-5.
2. Vanhegan IS, Malik AK, Jayakumar P, Ul Islam S, Haddad FS. A financial analysis of revision hip arthroplasty: the economic burden in relation to the national tariff. J Bone Joint Surg Am Br Vol 2012;94:619-23.
3. Patil S, Garbuz DS, Greidanus NV, Masri BA, Duncan CP. Quality of life outcomes in revision vs primary total hip arthroplasty: a prospective cohort study. J Arthroplasty 2008;23:550-3.
4. Inacio MC, Ake CF, Paxton EW, Khatod M, Wang C, Gross TP, et al. Sex and risk of hip implant failure: assessing total hip arthroplasty outcomes in the United States. JAMA Intern Med 2013;173:435-41.
5. Willert HG, Ludwig J, Semlitsch M. Reaction of bone to methacrylate after hip arthroplasty: a long-term gross, light microscopic, and scanning electron microscopic study. J Bone Joint Surg Am Vol 1974;56:1368-82.
6. Willert HG, Semlitsch M. Reactions of the articular capsule to wear products of artificial joint prostheses. J Biomed Mater Res 1977;11:157-64.
7. Gallo J, Raska M, Mrazek F, Petrek M. Bone remodeling, particle disease and individual susceptibility to periprosthetic osteolysis. Physiol Res 2008;57:339-49.
8. Chen X, Bai C, Xie L, Zhang Y, Wang K. Inflammatory response to orthopedic biomaterials after total hip replacement. J Orthop Sci 2012;17:407-12.
9. Yang SY, Yu H, Gong W, Wu B, Mayton L, Costello R, et al. Murine model of prosthesis failure for the long-term study of aseptic loosening. J Orthop Sci 2007;25:603-11.
10. Green TR, Fisher J, Matthews JB, Stone MH, Ingham E. Effect of size and dose on bone resorption activity of macrophages by in vitro clinically relevant ultra high molecular weight polyethylene particles. J Biomed Mater Res 2000;53:490-7.
11. Huang Z, Ma T, Ren PG, Smith RL, Goodman SB. Effects of orthopedic polymer particles on chemotaxis of macrophages and mesenchymal stem cells. J Biomed Mater Res, Part A 2010;94:1264-9.
12. Ingham E, Green TR, Stone MH, Kowalski R, Watkins N, Fisher J. Production of TNF-alpha and bone resorbing activity by macrophages in response to different types of bone cement particles. Biomaterials 2000;21:1005-13.
13. Ma GK, Chiu R, Huang Z, Pearl J, Ma T, Smith RL, et al. Polymethylmethacrylate particle exposure causes changes in p38 MAPK and TGF-beta signaling in differentiating MC3T3-E1 cells. J Biomed Mater Res, Part A 2010;94:234-40.
14. Rao AJ, Nich C, Dhulipala LS, Gibon E, Valladares R, Zwingenberger S, et al. Local effect of IL-4 delivery on polyethylene particle induced osteolysis in the murine calvarium. J Biomed Mater Res, Part A 2013;101:1926-34.
15. Jiang Y, Jia T, Gong W, Wooley PH, Yang SY. Titanium particle-challenged osteoblasts promote osteoclastogenesis and osteolysis in a murine model of periprosthestic osteolysis. Acta Biomater 2013;9:7564-72.
16. Gallo J, Goodman SB, Konttinen YT, Raska M. Particle disease: biologic mechanisms of periprosthetic osteolysis in total hip arthroplasty. Innate Immun 2013;19:213-24.
17. Nich C, Takakubo Y, Pajarinen J, Ainola M, Salem A, Sillat T, et al. Macrophages-Key cells in the response to wear debris from joint replacements. J Biomed Mater Res, Part A 2013;101:3033-45.
18. Goldring SR, Schiller AL, Roelke M, Rourke CM, O'Neil DA, Harris WH. The synovial-like membrane at the bone-cement interface in loose total hip replacements and its proposed role in bone lysis. J Bone Joint Surg Am Vol 1983;65:575-84.
19. Ito S, Matsumoto T, Enomoto H, Shindo H. Histological analysis and biological effects of granulation tissue around loosened hip prostheses in the development of osteolysis. J Orthop Sci 2004;9:478-87.
20. Meinecke I, Pap G, Mendoza H, Drange S, Ender S, Strietholt S, et al. Small ubiquitin-like modifier 1 [corrected] mediates the resistance of prosthesisloosening fibroblast-like synoviocytes against Fas-induced apoptosis. Arthritis Rheum 2009;60:2065-70.
21. Koreny T, Tunyogi-Csapo M, Gal I, Vermes C, Jacobs JJ, Glant TT. The role of fibroblasts and fibroblast-derived factors in periprosthetic osteolysis. Arthritis Rheum 2006;54:3221-32.
22. Shi Q, Lajeunesse D, Reboul P, Martel-Pelletier J, Pelletier JP, Dehnade F, et al. Metabolic activity of osteoblasts from periprosthetic trabecular bone in failed total hip arthroplasties and osteoarthritis as markers of osteolysis and loosening. J Rheumatol 2002;29:1437-45.
23. Engh CA, Hooten Jr JP, Zettl-Schaffer KF, Ghaffarpour M, McGovern TF, Bobyn JD. Evaluation of bone ingrowth in proximally and extensively porous-coated anatomic medullary locking prostheses retrieved at autopsy. J Bone Joint Surg Am Vol 1995;77:903-10.
24. Jasty M, Maloney WJ, Bragdon CR, Haire T, Harris WH. Histomorphological studies of the long-term skeletal responses to well fixed cemented femoral components. J Bone Joint Surg Am Vol 1990;72:1220-9.
25. Konttinen YT, Li TF, Xu JW, Tagaki M, Pirila L, Silvennoinen T, et al. Expression of laminins and their integrin receptors in different conditions of synovial membrane and synovial membrane-like interface tissue. Ann Rheum Dis 1999;58:683-90.
26. Schmalzried TP, Kwong LM, Jasty M, Sedlacek RC, Haire TC, O'Connor DO, et al. The mechanism of loosening of cemented acetabular components in total hip arthroplasty. Analysis of specimens retrieved at autopsy. Clin Orthop Relat Res 1992:60-78.
27. Takagi M, Santavirta S, Ida H, Ishii M, Takei I, Niissalo S, et al. High-turnover periprosthetic bone remodeling and immature bone formation around loose cemented total hip joints. J Bone Miner Res 2001;16:79-88.
28. Boehler M, Knahr K, Plenk Jr H, Walter A, Salzer M, Schreiber V. Long-term results of uncemented alumina acetabular implants. J Bone Joint Surg Br 1994;76:53-9.
29. Browne JA, Bechtold CD, Berry DJ, Hanssen AD, Lewallen DG. Failed metal-onmetal hip arthroplasties: a spectrum of clinical presentations and operative findings. Clin Orthop Relat Res 2010;468:2313-20.
30. Singh C, Kaplan A, Pambuccian SE. Necrotic granulomatous pseudotumor following metal-on-metal hip arthroplasty: a potential mimic of sarcoma on fine needle aspiration cytology. Diagn Cytopathol 2012;40(Suppl 2):E104-8.
31. Clarke MT, Roberts CP, Lee PT, Gray J, Keene GS, Rushton N. Polymerase chain reaction can detect bacterial DNA in aseptically loose total hip arthroplasties. Clin Orthop Relat Res 2004:132-7.
32. Horiki M, Nakase T, Myoui A, Sugano N, Nishii T, Tomita T, et al. Localization of RANKL in osteolytic tissue around a loosened joint prosthesis. J Bone Miner Metab 2004;22:346-51.
33. Konttinen YT, Takagi M, Mandelin J, Lassus J, Salo J, Ainola M, et al. Acid attack and cathepsin K in bone resorption around total hip replacement prosthesis. J Bone Miner Res 2001;16:1780-6.
34. Mandelin J, Li TF, Liljestrom M, Kroon ME, Hanemaaijer R, Santavirta S, et al. Imbalance of RANKL/RANK/OPG system in interface tissue in loosening of total hip replacement. J Bone Joint Surg Am Br 2003;85:1196-201.
35. Al Saffar N, Revell PA. Interleukin-1 production by activated macrophages surrounding loosened orthopaedic implants: a potential role in osteolysis. Br J Rheumatol 1994;33:309-16.
36. Baxter RM, Ianuzzi A, Freeman TA, Kurtz SM, Steinbeck MJ. Distinct immunohistomorphologic changes in periprosthetic hip tissues from historical and highly crosslinked UHMWPE implant retrievals. J Biomed Mater Res, Part A 2010;95:68-78.
37. Chiba J, Rubash HE, Kim KJ, Iwaki Y. The characterization of cytokines in the interface tissue obtained from failed cementless total hip arthroplasty with and without femoral osteolysis. Clin Orthop Relat Res 1994:304-12.
38. Crotti TN, Smith MD, Findlay DM, Zreiqat H, Ahern MJ, Weedon H, et al. Factors regulating osteoclast formation in human tissues adjacent to periimplant bone loss: expression of receptor activator NFkappaB, RANK ligand and osteoprotegerin. Biomaterials 2004;25:565-73.
39. Hercus B, Revell PA. Phenotypic characteristics of T lymphocytes in the interfacial tissue of aseptically loosened prosthetic joints. J Mater Sci Mater Med 2001;12:1063-7.
40. Hukkanen M, Corbett SA, Batten J, Konttinen YT, McCarthy ID, Maclouf J, et al. Aseptic loosening of total hip replacement. Macrophage expression of inducible nitric oxide synthase and cyclo-oxygenase-2, together with peroxynitrite formation, as a possible mechanism for early prosthesis failure. J Bone Joint Surg Am Br 1997;79:467-74.
41. Imai S, Konttinen YT, Jumppanen M, Lindy O, Ceponis A, Kemppinen P, et al. High levels of expression of collagenase-3 (MMP-13) in pathological conditions associated with a foreign-body reaction. J Bone Joint Surg Am Br 1998;80:701-10.
42. Jones LC, Frondoza C, Hungerford DS. Immunohistochemical evaluation of interface membranes from failed cemented and uncemented acetabular components. J Biomed Mater Res 1999;48:889-98.
43. Santavirta S, Hoikka V, Eskola A, Konttinen YT, Paavilainen T, Tallroth K. Aggressive granulomatous lesions in cementless total hip arthroplasty. J Bone Joint Surg Am Br 1990;72:980-4.
44. Solovieva SA, Ceponis A, Konttinen YT, Takagi M, Suda A, Eklund KK, et al. Mast cells in loosening of totally replaced hips. Clin Orthop Relat Res 1996:158-65.
45. Shen Z, Crotti TN, McHugh KP, Matsuzaki K, Gravallese EM, Bierbaum BE, et al. The role played by cell-substrate interactions in the pathogenesis of osteoclast-mediated peri-implant osteolysis. Arthritis Res Ther 2006;8:R70.
46. Takagi M, Konttinen YT, Santavirta S, Sorsa T, Eisen AZ, Nordsletten L, et al. Extracellular matrix metalloproteinases around loose total hip prostheses. Acta Orthop Scand 1994;65:281-6.
47. Witzleb WC, Hanisch U, Kolar N, Krummenauer F, Guenther KP. Neo-capsule tissue reactions in metal-on-metal hip arthroplasty. Acta Orthop 2007;78:211-20.
48. Xu JW, Li TF, Partsch G, Ceponis A, Santavirta S, Konttinen YT. Interleukin-11 (IL-11) in aseptic loosening of total hip replacement (THR). Scand J Rheumatol 1998;27:363-7.
49. Xu JW, Konttinen YT, Li TF, Waris V, Lassus J, Matucci-Cerinic M, et al. Production of platelet-derived growth factor in aseptic loosening of total hip replacement. Rheumatol Int 1998;17:215-21.
50. Xu JW, Konttinen YT, Waris V, Patiala H, Sorsa T, Santavirta S. Macrophagecolony stimulating factor (M-CSF) is increased in the synovial-like membrane of the periprosthetic tissues in the aseptic loosening of total hip replacement (THR). Clin Rheumatol 1997;16:243-8.
51. Zhang Y, Hou C, Yu S, Xiao J, Zhang Z, Zhai Q, et al. IRAK-M in macrophages around septically and aseptically loosened hip implants. J Biomed Mater Res, Part A 2012;100:261-8.
52. Gehrke T, Sers C, Morawietz L, Fernahl G, Neidel J, Frommelt L, et al. Receptor activator of nuclear factor kappaB ligand is expressed in resident and inflammatory cells in aseptic and septic prosthesis loosening. Scand J Rheumatol 2003;32:287-94.
53. Grimaud E, Soubigou L, Couillaud S, Coipeau P, Moreau A, Passuti N, et al. Receptor activator of nuclear factor kappaB ligand (RANKL)/osteoprotegerin (OPG) ratio is increased in severe osteolysis. Am J Pathol 2003;163:2021-31.
54. Ma GF, Ali A, Verzijl N, Hanemaaijer R, TeKoppele J, Konttinen YT, et al. Increased collagen degradation around loosened total hip replacement implants. Arthritis Rheum 2006;54:2928-33.
55. Mandelin J, Li TF, Hukkanen MV, Liljestrom M, Chen ZK, Santavirta S, et al. Increased expression of a novel osteoclast-stimulating factor, ADAM8, in interface tissue around loosened hip prostheses. J Rheumatol 2003;30:2033-8.
56. Morawietz L, Classen RA, Schroder JH, Dynybil C, Perka C, Skwara A, et al. Proposal for a histopathological consensus classification of the periprosthetic interface membrane. J Clin Pathol 2006;59:591-7.
57. Pajarinen J, Cenni E, Savarino L, Gomez-Barrena E, Tamaki Y, Takagi M, et al. Profile of toll-like receptor-positive cells in septic and aseptic loosening of total hip arthroplasty implants. J Biomed Mater Res, Part A 2010;94:84-92.
58. Park YS, Moon YW, Lim SJ, Yang JM, Ahn G, Choi YL. Early osteolysis following second-generation metal-on-metal hip replacement. J Bone Joint Surg Am Vol 2005;87:1515-21.
59. Revell PA, Jellie SE. Interleukin 15 production by macrophages in the implant interface membrane of aseptically loosened joint replacements. J Mater Sci Mater Med 1998;9:727-30.
60. Edwards J, Schulze E, Sabokbar A, Gordon-Andrews H, Jackson D, Athanasou NA. Absence of lymphatics at the bone-implant interface: implications for periprosthetic osteolysis. Acta Orthop 2008;79:289-94.
61. Landgraeber S, von Knoch M, Loer F, Brankamp J, Tsokos M, Grabellus F, et al. Association between apoptotis and CD4(+)/CD8(+) T-lymphocyte ratio in aseptic loosening after total hip replacement. Int J Biol Sci 2009;5:182-91.
62. Landgraeber S, Toetsch M, Wedemeyer C, Saxler G, Tsokos M, von Knoch F, et al. Over-expression of p53/BAK in aseptic loosening after total hip replacement. Biomaterials 2006;27:3010-20.
63. Landgraeber S, von Knoch M, Loer F, Wegner A, Tsokos M, Hussmann B, et al. Extrinsic and intrinsic pathways of apoptosis in aseptic loosening after total hip replacement. Biomaterials 2008;29:3444-50.
64. Nakashima Y, Sun DH, Trindade MC, Chun LE, Song Y, Goodman SB, et al. Induction of macrophage C-C chemokine expression by titanium alloy and bone cement particles. J Bone Joint Surg Am Br 1999;81:155-62.
65. Veigl D, Niederlova J, Krystufkova O. Periprosthetic osteolysis and its association with RANKL expression. Physiol Res 2007;56:455-62.
66. Yang F, Wu W, Cao L, Huang Y, Zhu Z, Tang T, et al. Pathways of macrophage apoptosis within the interface membrane in aseptic loosening of prostheses. Biomaterials 2011;32:9159-67.
67. Nygaard M, Elling F, Bastholm L, Soballe K, Borgwardt A. No difference in early cellular response of the pseudo-synovial membrane after total hip arthroplasty: comparison of 3 combinations of bearing materials. Acta Orthop 2006;77:402-12.
68. Santavirta S, Xu JW, Hietanen J, Ceponis A, Sorsa T, Kontio R, et al. Activation of periprosthetic connective tissue in aseptic loosening of total hip replacements. Clin Orthop Relat Res 1998:16-24.
69. Sabbatini M, Piffanelli V, Boccafoschi F, Gatti S, Reno F, Bosetti M, et al. Different apoptosis modalities in periprosthetic membranes. J Biomed Mater Res, Part A 2010;92:175-84.
70. Kwon YM, Ostlere SJ, McLardy-Smith P, Athanasou NA, Gill HS, Murray DW. "Asymptomatic" pseudotumors after metal-on-metal hip resurfacing arthroplasty: prevalence and metal ion study. J Arthroplasty 2011;26:511-8.
71. Mirra JM, Amstutz HC, Matos M, Gold R. The pathology of the joint tissues and its clinical relevance in prosthesis failure. Clin Orthop Relat Res 1976:221-40.
72. Morawietz L, Tiddens O, Mueller M, Tohtz S, Gansukh T, Schroeder JH, et al. Twenty-three neutrophil granulocytes in 10 high-power fields is the best histopathological threshold to differentiate between aseptic and septic endoprosthesis loosening. Histopathology 2009;54:847-53.
73. Bori G, Munoz-Mahamud E, Garcia S, Mallofre C, Gallart X, Bosch J, et al. Interface membrane is the best sample for histological study to diagnose prosthetic joint infection. Modern Pathol 2011;24:579-84.
74. Athanasou NA, Pandey R, de Steiger R, Crook D, Smith PM. Diagnosis of infection by frozen section during revision arthroplasty. J Bone Joint Surg Am Br 1995;77:28-33.
75. Tohtz SW, Muller M, Morawietz L, Winkler T, Perka C. Validity of frozen sections for analysis of periprosthetic loosening membranes. Clin Orthop Relat Res 2010;468:762-8.
76. Musso AD, Mohanty K, Spencer-Jones R. Role of frozen section histology in diagnosis of infection during revision arthroplasty. Postgrad Med J 2003;79:590-3.
77. Della Valle CJ, Scher DM, Kim YH, Oxley CM, Desai P, Zuckerman JD, et al. The role of intraoperative Gram stain in revision total joint arthroplasty. J Arthroplasty 1999;14:500-4.
78. Spangehl MJ, Masterson E, Masri BA, O'Connell JX, Duncan CP. The role of intraoperative gram stain in the diagnosis of infection during revision total hip arthroplasty. J Arthroplasty 1999;14:952-6.
79. Ghanem E, Ketonis C, Restrepo C, Joshi A, Barrack R, Parvizi J. Periprosthetic infection: where do we stand with regard to Gram stain? Acta Orthop 2009;80:37-40.
80. Johnson AJ, Zywiel MG, Stroh DA, Marker DR, Mont MA. Should gram stains have a role in diagnosing hip arthroplasty infections? Clin Orthop Relat Res 2010;468:2387-91.
81. Bi Y, Collier TO, Goldberg VM, Anderson JM, Greenfield EM. Adherent endotoxin mediates biological responses of titanium particles without stimulating their phagocytosis. J Orthop Sci 2002;20:696-703.
82. Moojen DJ, van Hellemondt G, Vogely HC, Burger BJ, Walenkamp GH, Tulp NJ, et al. Incidence of low-grade infection in aseptic loosening of total hip arthroplasty. Acta Orthop 2010;81:667-73.
83. Lahdeoja T, Pajarinen J, Kouri VP, Sillat T, Salo J, Konttinen YT. Toll-like receptors and aseptic loosening of hip endoprosthesis-a potential to respond against danger signals? J Orthop Sci 2010;28:184-90.
84. Medzhitov R. Origin and physiological roles of inflammation. Nature 2008;454:428-35.
85. Yount NY, Yeaman MR. Peptide antimicrobials: cell wall as a bacterial target. Ann NY Acad Sci 2013;1277:127-38.
86. Gollwitzer H, Dombrowski Y, Prodinger PM, Peric M, Summer B, Hapfelmeier A, et al. Antimicrobial peptides and proinflammatory cytokines in periprosthetic joint infection. J Bone Joint Surg Am Vol 2013;95:644-51.
87. Pajarinen J, Kouri VP, Jamsen E, Li TF, Mandelin J, Konttinen YT. The response of macrophages to titanium particles is determined by macrophage polarization. Acta Biomater 2013;9:9229-40.
88. Goodman SB, Huie P, Song Y, Schurman D, Maloney W, Woolson S, et al. Cellular profile and cytokine production at prosthetic interfaces. Study of tissues retrieved from revised hip and knee replacements. J Bone Joint Surg Am Br 1998;80:531-9.
89. Fujishiro T, Moojen DJ, Kobayashi N, Dhert WJ, Bauer TW. Perivascular and diffuse lymphocytic inflammation are not specific for failed metal-on-metal hip implants. Clin Orthop Relat Res 2011;469:1127-33.
90. Lennox DW, Schofield BH, McDonald DF, Riley Jr LH. A histologic comparison of aseptic loosening of cemented, press-fit, and biologic ingrowth prostheses. Clin Orthop Relat Res 1987:171-91.
91. Li TF, Santavirta S, Waris V, Lassus J, Lindroos L, Xu JW, et al. No lymphokines in T cells around loosened hip prostheses. Acta Orthop Scand 2001;72:241-7.
92. Aroukatos P, Repanti M, Repantis T, Bravou V, Korovessis P. Immunologic adverse reaction associated with low-carbide metal-on-metal bearings in total hip arthroplasty. Clin Orthop Relat Res 2010;468:2135-42.
93. Davies AP, Willert HG, Campbell PA, Learmonth ID, Case CP. An unusual lymphocytic perivascular infiltration in tissues around contemporary metalon- metal joint replacements. J Bone Joint Surg Am Vol 2005;87:18-27.
94. Hatton A, Nevelos JE, Nevelos AA, Banks RE, Fisher J, Ingham E. Alumina-alumina artificial hip joints. Part I. A histological analysis and characterisation of wear debris by laser capture microdissection of tissues retrieved at revision. Biomaterials 2002;23:3429-40.
95. Miyanishi K, Trindade MC, Ma T, Goodman SB, Schurman DJ, Smith RL. Periprosthetic osteolysis: induction of vascular endothelial growth factor from human monocyte/macrophages by orthopaedic biomaterial particles. J Bone Miner Res 2003;18:1573-83.
96. Kenna TJ, Brown MA. The role of IL-17-secreting mast cells in inflammatory joint disease. Nat Rev Rheumatol 2013;9:375-9.
97. Santavirta S, Pajamaki J, Eskola A, Konttinen YT, Lindholm T. Proliferative cell response to loosening of total hip replacements: a cytofluorographic cell cycle analysis. Arch Orthop Trauma Surg 1991;111:43-6.
98. Santavirta S, Ceponis A, Solovieva SA, Hurri H, Jin J, Takagi M, et al. Periprosthetic microvasculature in loosening of total hip replacement. Arch Orthop Trauma Surg 1996;115:286-9.
99. Niissalo S, Li TF, Santavirta S, Takagi M, Hietanen J, Konttinen YT. Dense innervation in pseudocapsular tissue compared to aneural interface tissue in loose totally replaced hips. J Rheumatol 2002;29:796-803.
100. Goodman SB, Huie P, Song Y, Lee K, Doshi A, Rushdieh B, et al. Loosening and osteolysis of cemented joint arthroplasties. A biologic spectrum. Clin Orthop Relat Res 1997:149-63.
101. Li TF, Mandelin J, Hukkanen MV, Liljestrom M, Santavirta S, Westerlund J, et al. Expression of caspase-1 in synovial membrane-like interface tissue around loosened hip prostheses. Rheumatol Int 2002;22:97-102.
102. Neale SD, Athanasou NA. Cytokine receptor profile of arthroplasty macrophages, foreign body giant cells and mature osteoclasts. Acta Orthop Scand 1999;70:452-8.
103. Konttinen YT, Waris V, Xu JW, Jiranek WA, Sorsa T, Virtanen I, et al. Transforming growth factor-beta 1 and 2 in the synovial-like interface membrane between implant and bone in loosening of total hip arthroplasty. J Rheumatol 1997;24:694-701.
104. Waris V, Sillat T, Waris E, Virkki L, Mandelin J, Takagi M, et al. Role and regulation of VEGF and its receptors 1 and 2 in the aseptic loosening of total hip implants. J Orthop Sci 2012;30:1830-6.
105. Spanogle JP, Miyanishi K, Ma T, Epstein NJ, Smith RL, Goodman SB. Comparison of VEGF-producing cells in periprosthetic osteolysis. Biomaterials 2006;27:3882-7.
106. Arora A, Song Y, Chun L, Huie P, Trindade M, Smith RL, et al. The role of the TH1 and TH2 immune responses in loosening and osteolysis of cemented total hip replacements. J Biomed Mater Res, Part A 2003;64:693-7.
107. Li TF, Xu JW, Santavirta S, Takagi M, Virtanen I, Pirila L, et al. Expression of vitronectin and its integrin receptors in the synovial membrane-like interface tissue from aseptic loosening of total hip replacement. J Rheumatol 2000;27:727-34.
108. Krenn V, Morawietz L, Kienapfel H, Ascherl R, Matziolis G, Hassenpflug J, et al. Revised consensus classification. Histopathological classification of diseases associated with joint endoprostheses. Z. Rheumatol. 2013;72:383-92.
109. Kim KJ, Chiba J, Rubash HE. In vivo and in vitro analysis of membranes from hip prostheses inserted without cement. J Bone Joint Surg Am Vol 1994;76:172-80.
110. Goodman SB, Chin RC, Chiou SS, Schurman DJ, Woolson ST, Masada MP. A clinical-pathologic-biochemical study of the membrane surrounding loosened and nonloosened total hip arthroplasties. Clin Orthop Relat Res 1989:182-7.
111. Campbell P, Ebramzadeh E, Nelson S, Takamura K, De Smet K, Amstutz HC. Histological features of pseudotumor-like tissues from metal-on-metal hips. Clin Orthop Relat Res 2010;468:2321-7.
112. Esposito C, Maclean F, Campbell P, Walter WL, Walter WK, Bonar SF. Periprosthetic tissues from third generation alumina-on-alumina total hip arthroplasties. J Arthroplasty 2013;28:860-6.
113. von Domarus C, Rosenberg JP, Ruther W, Zustin J. Necrobiosis and Tlymphocyte infiltration in retrieved aseptically loosened metal-onpolyethylene arthroplasties. Acta Orthop 2011;82:596-601.
114. Carli A, Reuven A, Zukor DJ, Antoniou J. Adverse soft-tissue reactions around non-metal-on-metal total hip arthroplasty - a systematic review of the literature. Bull NYU Hospital Joint Dis 2011;69(Suppl 1):S47-51.
115. Goodman SB, Knoblich G, O'Connor M, Song Y, Huie P, Sibley R. Heterogeneity in cellular and cytokine profiles from multiple samples of tissue surrounding revised hip prostheses. J Biomed Mater Res 1996;31:421-8.
116. Sundfeldt M, Carlsson LV, Johansson CB, Thomsen P, Gretzer C. Aseptic loosening, not only a question of wear: a review of different theories. Acta Orthop 2006;77:177-97.
117. Aspenberg P, Van der Vis H. Migration, particles, and fluid pressure. A discussion of causes of prosthetic loosening. Clin Orthop Relat Res 1998:75-80.
118. Hallab NJ, Jacobs JJ. Biologic effects of implant debris. Bull NYU Hospital Joint Dis 2009;67:182-8.
119. Reno F, Sabbatini M, Masse A, Bosetti M, Cannas M. Fibroblast apoptosis and caspase-8 activation in aseptic loosening. Biomaterials 2003;24:3941-6.
120. Li TF, Santavirta S, Virtanen I, Kononen M, Takagi M, Konttinen YT. Increased expression of EMMPRIN in the tissue around loosened hip prostheses. Acta Orthop Scand 1999;70:446-51.
121. Takei I, Takagi M, Santavirta S, Ida H, Ishii M, Ogino T, et al. Messenger ribonucleic acid expression of 16 matrix metalloproteinases in bone-implant interface tissues of loose artificial hip joints. J Biomed Mater Res 2000;52:613-20.
122. Thomas P, Braathen LR, Dorig M, Aubock J, Nestle F, Werfel T, et al. Increased metal allergy in patients with failed metal-on-metal hip arthroplasty and peri-implant T-lymphocytic inflammation. Allergy 2009;64:1157-65.
123. Lohmann CH, Meyer H, Nuechtern JV, Singh G, Junk-Jantsch S, Schmotzer H, et al. Periprosthetic tissue metal content but not serum metal content predicts the type of tissue response in failed small-diameter metal-on-metal total hip arthroplasties. J Bone Joint Surg Am Vol 2013;95:1561-8.
124. Thyssen JP, Jakobsen SS, Engkilde K, Johansen JD, Soballe K, Menne T. The association between metal allergy, total hip arthroplasty, and revision. Acta Orthop 2009;80:646-52.
125. Martin SF. Contact dermatitis: from pathomechanisms to immunotoxicology. Exp Dermatol 2012;21:382-9.
126. Atilla B, Atilla P, Tokgozoglu AM, Cakar AN, Alpaslan AM. Immunohistochemical evaluation of periprosthetic membrane from loose cemented and uncemented total hip arthroplasty. Saudi Med J 2005;26:429-33.
127. Willert HG, Buchhorn GH, Fayyazi A, Flury R, Windler M, Koster G, et al. Metal-on-metal bearings and hypersensitivity in patients with artificial hip joints. A clinical and histomorphological study. J Bone Joint Surg Am 2005;87:28-36.
128. Mahendra G, Pandit H, Kliskey K, Murray D, Gill HS, Athanasou N. Necrotic and inflammatory changes in metal-on-metal resurfacing hip arthroplasties. Acta Orthop 2009;80:653-9.
129. Konttinen YT, Pajarinen J. Adverse reactions to metal-on-metal implants. Nat Rev Rheumatol 2013;9:5-6.
130. Evans EM, Freeman MA, Miller AJ, Vernon-Roberts B. Metal sensitivity as a cause of bone necrosis and loosening of the prosthesis in total joint replacement. J Bone Joint Surg Am Br 1974;56-B:626-42.
131. Korovessis P, Petsinis G, Repanti M, Repantis T. Metallosis after contemporary metal-on-metal total hip arthroplasty. Five to nine-year follow-up. J Bone Joint Surg Am 2006;88:1183-91.
132. Langton DJ, Jameson SS, Joyce TJ, Hallab NJ, Natu S, Nargol AV. Early failure of metal-on-metal bearings in hip resurfacing and large-diameter total hip replacement: a consequence of excess wear. J Bone Joint Surg Am Br 2010;92:38-46.
133. Ng VY, Lombardi Jr AV, Berend KR, Skeels MD, Adams JB. Perivascular lymphocytic infiltration is not limited to metal-on-metal bearings. Clin Orthop Relat Res 2011;469:523-9.
134. Milosev I, Trebse R, Kovac S, Cor A, Pisot V. Survivorship and retrieval analysis of Sikomet metal-on-metal total hip replacements at a mean of seven years. J Bone Joint Surg Am Vol 2006;88:1173-82.
135. Baxter RM, Freeman TA, Kurtz SM, Steinbeck MJ. Do tissues from THA revision of highly crosslinked UHMWPE liners contain wear debris and associated inflammation? Clin Orthop Relat Res 2011;469: 2308-17.
136. Dabbs D. Diagnostic immunohistochemistry: theranostic and genomic applications. 3rd ed. Philadelphia, PA: Saunders; 2010.
137. Burry RW. Immunocytochemistry: a practical guide for biomedical research. New York: Springer; 2010.
138. Farm AJ, Stead RH. Fixation and processing. In: Kumar GL, Rudbeck L, editors. Education guide: immunohistochemical staining methods, 5th ed. Carpinteria, CA: DAKO North America, 2009. p. 29-35.
139. Kim YH, Kim VE. Early migration of uncemented porous coated anatomic femoral component related to aseptic loosening. Clin Orthop Relat Res 1993:146-55.
140. Lukas Z, Feit J. Immunohistochemical methods in biology and surgical pathology. Brno: Masaryk University, Medical Faculty; 1997.
141. Cregger M, Berger AJ, Rimm DL. Immunohistochemistry and quantitative analysis of protein expression. Arch Pathol Lab Med 2006;130:1026-30.
142. Matos LL, Stabenow E, Tavares MR, Ferraz AR, Capelozzi VL, Pinhal MA. Immunohistochemistry quantification by a digital computer-assisted method compared to semiquantitative analysis. Clinics 2006;61:417-24.
143. Rizzardi AE, Johnson AT, Vogel RI, Pambuccian SE, Henriksen J, Skubitz AP, et al. Quantitative comparison of immunohistochemical staining measured by digital image analysis versus pathologist visual scoring. Diagn Pathol 2012;7:42.